Market Closed - Nasdaq Other stock markets | After market 07:06:14 pm | |||
12.1 USD | -0.78% | | 12.14 | +0.41% |
Jun. 28 | Walgreens' Q3 Earnings Miss Reflects Weak Consumer Spending, Pharmacy Headwinds, Morgan Stanley Says | MT |
Jun. 28 | Walgreens' Earnings Guidance Cut Implies 'Notably Weaker' Fourth Quarter, Morgan Stanley Says | MT |
This article is reserved for members
Already a member?
Log In
Not a member ?
Free registration
Latest news about Walgreens Boots Alliance, Inc.
Walgreens' Q3 Earnings Miss Reflects Weak Consumer Spending, Pharmacy Headwinds, Morgan Stanley Says | MT | |
Walgreens' Earnings Guidance Cut Implies 'Notably Weaker' Fourth Quarter, Morgan Stanley Says | MT | |
Walgreens Boots Alliance's Fiscal Q3 Results Reflect Pharmacy Headwinds, Challenging Retail Environment, Truist Securities Says | MT | |
BofA Securities Slashes Price Target on Walgreens Boots Alliance to $11 From $22, Maintains Underperform Rating | MT | |
Truist Cuts Price Target on Walgreens Boots Alliance to $13 From $20, Calls Fiscal Q3 'Difficult,' Keeps Hold Rating | MT | |
Mizuho Adjusts Price Target on Walgreens Boots Alliance to $15 From $19, Maintains Neutral Rating | MT | |
Morgan Stanley Lowers Price Target on Walgreens Boots Alliance to $9 From $13 Amid Guidance Cut, Keeps Underweight Rating | MT | |
Barclays Adjusts Price Target on Walgreens Boots Alliance to $11 From $15, Maintains Underweight Rating | MT | |
Deutsche Bank Adjusts Price Target on Walgreens Boots Alliance to $13 From $22, Maintains Hold Rating | MT | |
Wall St. subdued ahead of debate, inflation data | RE | |
Equities Rise as Markets Analyze Fed Official's Remarks, Macro Data | MT | |
Equities Rise Amid Fed Official's Rate Remarks, Macro Data | MT | |
US Equities Markets Close Higher Thursday as Investors Review Economic Data, Fed Official's Remarks | MT | |
Sector Update: Health Care Stocks Slipping Late Afternoon | MT | |
Wall Street closes subdued as investors sit, wait for inflation data | RE | |
Leerink Partners Cuts Walgreens Boots Alliance's Price Target to $11 From $17 | MT | |
Equity Markets Rise Intraday After Macro Data, Fed Official's Comments | MT | |
Sector Update: Health Care Stocks Decline in Afternoon Trading | MT | |
Sector Update: Health Care | MT | |
Nephron Research Cuts Walgreens Boots Alliance's Price Target to $13 From $24, Hold Rating Maintained | MT | |
US Equity Indexes Choppy, Treasury Yields Decline in Midday Trading | MT | |
Walgreens cuts profit view, looks to shut more stores | RE | |
Evercore ISI Adjusts Price Target on Walgreens Boots Alliance to $10 From $17 | MT | |
Wall St listless as eyes on crucial inflation data; Micron, Walgreens slump | RE | |
Top Midday Stories: Walgreens Shares Tumble on Lower Guidance, Store Closures; SM Energy, NOG to Buy XCL Resources; Uber, Lyft Worker Classification Heads to Massachusetts Ballot | MT |
Chart Walgreens Boots Alliance, Inc.
More charts
Company Profile
Walgreens Boots Alliance, Inc. specializes in the distribution of pharmaceutical products. Net sales break down by activity as follows:- retail distribution (87.2%): selling prescription drugs, OTC medicines, beauty and cosmetic products, etc. in the United States (90.9% of net sales) and internationally (9.1%). At the end of August 2023, the activity is carried out through 13,532 outlets (of which 8,706 located in the United States, Puerto Rico and the US Virgin Islands), and through the Internet;- wholesale distribution (8.1%).The remaining sales (4.7%) are from the healthcareNet sales break down geographically as follows: the United States (84%), Germany (8.1%), the United Kingdom (6.5%) and other (1.4%).
Sector
Drug Retailers
Calendar
2024-10-09 - Q4 2024 Earnings Release (Projected)
Related indices
More about the company
Income Statement Evolution
More financial data
Analysis / Opinion
More Strategies
Ratings for Walgreens Boots Alliance, Inc.
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Analysts' Consensus
Sell
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
12.1USD
Average target price
17.4USD
Spread / Average Target
+43.82%
Consensus
EPS Revisions
Estimates Revisions
Quarterly earnings - Rate of surprise
Company calendar
Sector Other Drug Retailers
1st Jan change | Capi. | |
---|---|---|
WALGREENS BOOTS ALLIANCE, INC. | -53.68% | 10.52B |
JD HEALTH INTERNATIONAL INC. | -45.65% | 8.72B |
ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED | -26.18% | 6.55B |
-7.49% | 6.05B | |
CORPORATIVO FRAGUA, S.A.B. DE C.V. | +85.61% | 4.84B |
NAHDI MEDICAL COMPANY | -3.80% | 4.57B |
CLICKS GROUP LIMITED | +5.73% | 4.3B |
YIFENG PHARMACY CHAIN CO., LTD. | -26.42% | 4.27B |
WELCIA HOLDINGS CO., LTD. | -18.65% | 2.59B |
SAUDI CHEMICAL HOLDING COMPANY | +161.11% | 2.54B |
Other Drug Retailers
- Stock Market
- Equities
- WBA Stock
- News Walgreens Boots Alliance, Inc.
- Mizuho Securities Adjusts Price Target on Walgreens Boots Alliance to $19 From $23